baber/WOPTO huggingface dataset:
Patent IL-114539-A0 (IL)
Title: Label inserting method and apparatus
IPC: B29C45/42
Filed: 1995-07-11
Abstract: PCT No. PCT/EP95/02505 Sec. 371 Date Mar. 10, 1997 Sec. 102(e) Date Mar. 10, 1997 PCT Filed Jun. 27, 1995 PCT Pub. No. WO96/02378 PCT Pub. Date Feb. 1, 1996The present invention relates to a method for providing at least one insertion label on a tool of a machine, the insertion label being insertable into a mold half of a tool of a plastics processing machine, in particular injection molding machine or deep-drawing machine. In this method insertion labels are punched out of label web material by means of a punching device consisting essentially of a punching plate and a cutting tool. The insertion labels are transferred by a carrier, which belongs to the punching device, to the tool of the machine and are discharged for insertion thereinto. So far a great problem has consisted in performing such a transfer in such a manner that the insertion label is positioned in a sufficiently precise manner without creases. This problem is overcome in that after the punching operation the insertion labels are held by the punching plate which is movable substantially in a direction transverse to the punching direction and formed as a carrier, and are transferred to the tool of the machine. Furthermore, the present invention relates to an apparatus for performing the method.
Patent IL-128411-A0 (IL)
Title: Neuritin, a neurogene
IPC: C07K14/52
Filed: 1997-08-07
Abstract: Disclosed are DNA and amino acid sequences for a novel polypeptide termed Neuritin which is expressed primarily in selected regions of the brain.
Patent IL-134162-A0 (IL)
Title: Emulsions of peroxyesters
IPC: C07C409/00
Filed: 1998-06-16
Abstract: The invention relates to aqueous emulsions of peroxyesters comprising an anti-freeze agent, a polyvinyl acetate with a degree of hydrolysis between 45 and 68%, and a non-ionic surfactant with an HLB value greater than 16 selected from alkylene oxide block-copolymers, ethoxylated fatty alcohols, and ethoxylated fatty acids. The emulsions are safe, storage stable, and generally applicable.
Patent IL-136784-A0 (IL)
Title: Compositions and method for protecting skin from uv induced immunosuppression and skin damage
IPC: A61K8/49
Filed: 1998-12-21
Abstract: A method for protecting skin from either UV-induced immunosuppression or from UV-induced skin damage comprising the topical administration of a composition containing an extract of soy or clover, and/or the isoflavone compounds genistein, biochanin, dihydro-daidzein, diadzein, formonentin, dihydro-geneistein, 2-dehydro-O-desmethyl-angolensin, tetrahydro-daidzein, equol, dehydro-equol, O-desmethyl-angolensin, or 6-hydroxy-O-desmethyl-angolensin. The invention also comprises compositions containing these compounds.
Patent IL-145240-A0 (IL)
Title: Method of treating eating disorders
IPC: A61K31/137
Filed: 2000-03-17
Abstract: A compound of formula Ior a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating eating disorders, such as anorexia nervosa, bulimia nervosa, weight-gain after smoking cessation, snacking or binge eating.
Patent IL-147283-A0 (IL)
Title: Relation path viability prediction
IPC: G06F17/30
Filed: 2000-06-29
Abstract: There is provided a process for predicting whether a query will produce a result in an information system formed of objects having different instances and relations between the objects. An instance-to-object bitmap is computed off-line, before queries are generated by a user: the bitmap is used to represent the existence of a relation path from instances to the other objects of a database. When a query is generated, the bitmap is accessed to predict whether there exists a relation from the instance to the object, that is whether the query will issue a result. The process makes it possible for a user to abort queries without consuming run-time. It also makes it possible to guide users through navigation of a Webpage or the like, by suggesting relations that will produce results.
Patent IL-148512-A0 (IL)
Title: Methods for making recombinant proteins using apoptosis inhibitors
IPC: C12N15/34
Filed: 2000-09-25
Abstract: The invention provides improved methods of making and producing recombinant proteins in  in vitro  cultures of host cells using apoptosis inhibitors. The use of one or more apoptosis inhibitors in the methods can reduce apoptosis in the cell cultures and markedly improve yield of
Patent IL-149779-A0 (IL)
Title: A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
IPC: A61P31/04
Filed: 2000-11-23
Abstract: The invention relates to vaccines for treating prostate inflammation and benign prostate hyperplasias (stages I and II) comprising Lactobacillus strains in an inactivated form and carriers and/or excipients commonly used in vaccine preparations.
Patent IL-163747-A0 (IL)
Title: Damping element for a shoe puma aktiengesellschaft
IPC: A43B13/40
Filed: 2003-04-15
Abstract: Damping element comprises a first element in an unloaded state and defining an absorption space, a smaller second element, also in an unloaded state and coaxial to the first element, comprising a hollow body. The elements are bound together using an elastic connecting element.
Patent IL-174537-A0 (IL)
Title: Pharmaceutical combinations of hydrocodone and naltrexone
IPC: A61K31/485
Filed: 2006-03-23
Abstract: Disclosed is a pharmaceutical composition comprising from about 5 to about 20 mg of hydrocodone or a pharmaceutically acceptable salt thereof and from 0.055 to about 0.56 mg naltrexone or pharmaceutically acceptable salt thereof.
Patent IL-175510-A0 (IL)
Title: Use of il-6 type cytokines for maturation of oocytes
IPC: C12N5/075
Filed: 2006-05-09
Abstract: The use of certain IL-6-type cytokines for the  in vitro  maturation of mammalian oocytes is described. The  in vitro  fertilisation protocols.
Patent IL-177349-A0 (IL)
Title: Improvements in or relating to liquid flow control devices
IPC: F16K31/00
Filed: 2006-08-08
Abstract: The disclosure relates to a liquid flow control device (10) having a port or passageway (11) through which liquid flow is to be controlled. A body (12) of a liquid swellable material is located in the port or passageway having an upstream side and a downstream side in relation to the direction of liquid flow through the port or passageway. A layer of sealing material (17) is provided on the upstream side of the body to prevent contact of that side of the body with the liquid when the body is swollen to close the port or passageway whilst allowing contact of the downstream side of the body when the body is in the non-swollen condition allowing liquid flow through the port or passageway.
Patent IL-181586-A0 (IL)
Title: Silicate coating
Filed: 2007-02-27
Abstract: The invention relates to a method for forming a silicate coating on particles and to the particles thus obtained, characterized in that a solution containing silicate is added to a dispersion of uncoated particles having a diameter of less than 50 μm and acoustic excitation occurs.
Patent IL-205083-A0 (IL)
Title: Process for the preparation of tetranorlabdane derivatives
Filed: 2010-04-14
Abstract: The present invention concerns a process for the preparation of a compound of formula (I), wherein the dotted line is a single bond and n is 1 or the dotted line is a double bond and n is 0, and wherein the relative configuration is as shown, in the form of any one of its diastereoisomers or enantiomers or mixtures thereof.
Patent RO-125773-A0 (RO)
Title: Tin alloy for corrosionproof plating and process for obtaining the same
Inventor: FAUR MARIA
IPC: C22C13/00
Filed: 2010-04-26
Abstract: The invention relates to a tin alloy for corrosionproof plating and to a process meant for plating with resistance to corrosion and soldering capacity. According to the invention, the alloy consists of Sn base of minimum 98.85%, the alloying elements Cu=0.4...0.8% and Ti=0.1...0.2%, respectively, with a maximum content of impurities limited to the values Bi=0.03%, Sb=0.05%, Fe=0.01, Pb=0.05%, Zn=0.001% and Al=0.001%. As claimed, the process is performed by directly melting the metallic tin in the melting furnace of the installation for thermal deposition at a temperature ranging between 340...350°C followed by the charge overheating at temperatures ranging between 430...450°C and melting the SnCu14 and SnTi13 pre-alloys dosed depending on the charge size and the Cu and Ti content, the time for the smelting process ranges between 10...15 min and the alloy melting temperature is 237.5°C.
Patent RO-128123-A0 (RO)
Title: Cage for transporting european bisons
Inventor: CATANOIU SEBASTIAN
IPC: A01K1/03
Filed: 2012-06-21
Abstract: The invention relates to a cage for transporting European bisons in case of relocation thereof to other zones than the areas of origin. According to the invention, the cage has two side walls () which can swing in their lower half so as to form a ramp permitting the tranquilized animal to be easily introduced therein, the use of the cage with mobile semi-walls serving also to ergonomically position the tranquilized bison with its legs underneath, so that, when the tranquilizer effect ceases, the animal can rise, in the conditions of a cage the main purpose of which is to reduce the animal moving possibilities during transport, the cages being provided with some sliding or swinging safety systems (latches) (), respectively, and some holding systems () intended to allow the animal safe loading and unloading into/from the transportation means, the monitoring of the tranquilized animal being achieved through the rectangular sight hole located at the lower part of the front cover (), as well as through the rectangular sight hole located at the upper part of the right side wall ().
Patent AP-2001002179-A0 (AP)
Title: 2-Aminocarbonyl-9h-purine derivatives.
Inventor: MANTELL SIMON JOHN
IPC: C07H/
Filed: 2001-05-31
Abstract: The present invention relates to compounds of the formula: and pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
Patent IE-910293-A1 (IE)
Title: A Cross-Cut Saw Assembly
Inventor: LEEPER NORMAN
IPC: B23D59/00
Filed: 1991-01-29
Abstract: The cross-cut saw assembly (1) for cutting wood planks to desired lengths comprises a ground engaging support frame (2) with a pair of parallel beams (3, 4) on which a number of saw units (8, 9) are slidably mounted which are independently movable along the beams (3, 4) for selected relative spacing of the saw units (8, 9). Each saw unit (8, 9) has an independently driven circular saw (30). Feeder means is provided on each saw unit (8, 9) to deliver planks to the saws (30) and comprises an endless chain (38) having a number of spaced-apart outwardly extending workpiece feeders (39). Each chain (38) is independently driven by a motor (42) controlled by a microcomputer to operate on a continuous start-stop basis for stepped delivery of a plank to the saws (30).
Patent MA-19860-A1 (MA)
Inventor: GILBERT REGNIER
IPC: C07D473/12
Filed: 1983-07-28
Abstract: New xanthine compounds of the formula:   <IMAGE>   in which: R1 is hydrogen or alkyl from C1 to C5 inclusive; R2 is a hydrocarbon radical up to C6 having optionally a double bond, phenyl or benzyl; R3 is hydrogen, alkyl, hydroxyalkyl or dihydroxyalkyl each from C1 to C5 R4 represents:   <IMAGE>   in which: Y is hydrogen, halogen, alkyl or alkoxy from C1 to C5 or hydroxyl; Z is methylene or a straight or branched hydrocarbon radical from C2 to C5 optionally substituted by hydroxyl; and A is an amino group of the formula:   <IMAGE>   p being 2 or 3;   <IMAGE>   in which q is 1 or 2, and X is a single bond, oxygen or   <IMAGE>   in which R5 is hydrogen, alkyl or alkylene up to C5, or   <IMAGE>   in which m is an integer from 2 to 6 and R6 is alkyl from C1 to C5. These new compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of all diseases where it is necessary to inhibit the antigenic antibody reactions.
Patent MA-28206-A1 (MA)
Title: Agglo recuperable pour la construction des immeubles parmi le systeme du forgé reticulaire
Inventor: JUAN MUNTAL TRAVERIA
Filed: 2005-03-31
Abstract: Agglo récupérable pour la construction des immeubles au moyen du système du forgé réticulaire. Agglo récupérable pour la construction des immeubles moyennant le système du forgé réticulaire, il se caractérise par le fait qu'il constitue un ferraillage qui peut être formé de matière plastique, de fer galvanisé ou avec zinc. L'agglo récupérable est destiné pour la construction des immeubles moyennant le système des forgés réticulaires, tant pour les parmi étages que pour la couverture finale, pour les bloques de logements, usines, magasins, centres commerciales, hôtels, hôpitaux, écoles et tout autre type d'édification, spécialement celles des grandes superficies et / ou qui nécessitent des grands espaces entre les colonnes.
Patent MA-27848-A1 (MA)
Title: Formes posologiques d'azithromycine a effets secondaires reduits.
Inventor: THOMBRE AVINASH GOVIND
IPC: A61P31/04
Filed: 2005-12-08
Abstract: DEPOSANT Société dite : PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES US 4 Décembre 2003 60/527,084 US 23 Janvier 2004 10/763,340 Voir en annexe le titre de l'invention et le texte de l'abrégé Formes posologiques d'azithromycine à effets secondaires réduits Une forme posologique orale comprenant de l??azithromycine et une quantité efficace d'un agent alcalinisant. De préférence, ladite forme posologique orale comprend une quantité efficace d'un agent alcalinisant et une forme en particules multiples d1azithromycine, ladite forme en particules multiples comprenant de l??azithromycine, un mélange de monobéhénate de glycéryle, de dibéhénate de glycéryle et de tribéhénate de glycéryle, et un poloxamère. Habituellement, la forme posologique orale comprend n'importe quel moyen d'administration orale convenable tel qu'une poudre pour suspension orale, un paquet ou sachet de dose unitaire, un comprimé ou une capsule. Il est révélé en outre une suspension orale comprenant de l'azithromycine, une quantité efficace d'un agent alcalinisant et un véhicule. De préférence, l??azithromycine est une forme en particules multiples dans laquelle lesdites particules multiples comprennent de l'azithro-mycine, un mélange de monobéhénate de glycéryle, de dibéhénate de glycéryle et de tribéhénate de glycéryle, et un poloxamère. Il est révélé également une méthode pour réduire les effets secondaires gastro-intestinaux, associés à l'administration d1azithromycine à un mammifère, comprenant l'administration de manière contigue d'azithromycine et d'une quantité efficace d'un agent alcalinisant audit mammifère, la fréquence des effets secondaires gastro-intestinaux étant inférieure à celle constatée en administrant une dose égale d'azithromycine sans ledit agent alcalinisant. Il est révélé en outre une méthode pour le traitement d'une infection par des bactéries ou des protozoaires chez un mammifère nécessitant un tel traitement, comprenant l'administration de manière contigue audit mammifère d'une dose unique d'une forme posologique orale, ladite forme posologique orale comprenant del??azithromycine et une quantité efficace d'un agent alcalinisant. Il est révélé en outre une forme en particules multiples d'azithromycine comprenant del??azithromycine, un agent tensio-actif et un support pharmaceutiquement acceptable.
Patent MA-28285-A1 (MA)
Title: Dérivés de spiropipéridine pour lutter contre les organismes nuisibles
Inventor: MOLLEYRES LOUIS-PIERRE
IPC: A01N43/40
Filed: 2006-07-06
Abstract: Dérivés de spiropipéridine pour lutter contre les organismes nuisibles Utilisation d'un composé de formule I Y est une liaison simple, C=O, C=S ou S(O)m où m vaut 0, 1 ou 2 ; le cycle représenté par T est un cycle hétéroaromatique à 5 ou 6 chaînons et R1, R2, R3, R8 et Ra sont des groupes organiques spécifiés et p vaut 0, 1, 2, 3, 4, 5 ou 6 ; q vaut 0, 1, 2, 3, 4, 5 ou 6 ; p + q vaut 1, 2, 3, 4, 5 ou 6 ; ou des sels ou N-oxydes de ceux-ci ou des compositions les contenant destinés à lutter contre les insectes, acariens, nématodes ou mollusques ; de nouveaux composés sont également proposés.
Patent MA-41739-A1 (MA)
Title: Méthode de génération automatique des fichiers schématiques, fichiers d'empreintes et modèles 3d des composants électronique.
Inventor: NAGGAR OTHMANE
IPC: G06F17/50
Filed: 2017-12-29
Abstract: Le procédé de l’invention rentre dans le cadre du développement de carte électronique avec les outils de conception assistée par ordinateur. Ce procédé permet de générer automatiquement les fichiers nécessaires pour le design des composants à partir de fichier spécifique du composant "datasheet", il permet de générer les fichiers :- fichier schématique du composant - fichier d’empreinte du composant "footprint" - fichier 3d du composant "step"
Patent UY-23594-A1 (UY)
Title: Un elemento para nivelar tierra labrada
IPC: A01B31/00
Filed: 1993-06-07
Abstract: Se describe un aparato para nivelar tierras labradas del tipo que posee a lo menos una barra niveladora que apoya en el suelo, sobre esta barra tenemos una estructura constituida por perfiles que están adheridos a las barras con desprendimientos aproximadamente verticales de dicha estructura, lo que configura una forma similar a la U invertida en el caso de poseer más de una barra, a esta estructura es colocable barras para sostener contrapesos y por delante adherido a la estructura tiene por lo menos un elemento de tracción. Se caracteriza porque cada aparato es colocable a un armazón de tracción, constituyendo un conjunto nivelador integrado por una multiplicidad de aparatos niveladores, individualmente desplazantes en dirección vertical con uniones rotatorias de los elementos de tracción al armazón de tracción y uniones al suelo por medios de apoyo con movilidad. La figura 1 es una vista de costado del aparato.
Patent UY-24315-A1 (UY)
Title: Dispositivo de distribucion para la tecnica de telecomunicaciones y transmisión de datos.
Inventor: DOHNKE INGO
IPC: H02G11/00
Filed: 1996-08-23
Abstract: La invención se refiere a una regleta de terminales para la técnica de telecomunicaciones y transmisión de datos, especialmente para el distribuidor general de las líneas telefónicas y de datos, con elementos de contacto de corte-borne para la conexión tanto de los cables de abonado como de central, con resortes de contacto formados de una sola pieza y dispuestos en el interior de la regleta de terminales de estructura modular. Se caracteriza porque los resortes de contacto (2) de una sola pieza que están dispuestos en el interior de la regleta de terminales (1), están formados por contactos de conexión de la técnica de corte-borne (9, 13) en los lados anterior y posterior de la regleta y por un contacto de telecomunicación (10) en la zona central, en cuyo caso el contacto de telecomunicación consiste en por lo menos dos superficies de contacto (14, 15), que pueden estar configuradas como contactos dobles, así como en una superficie de soporte (16), sobre la cual actúa una lengüeta (17) con una leva (18), que está empalmada como una sola pieza con las partes superior e inferior (4, 3), respectivamente, de la regleta y porque un contacto de toma (12) está configurado en la zona anterior del resorte de contacto. Los numeros hacen referencia a la figura 1 la cual representa dicha invención.
Patent UY-24847-A1 (UY)
Title: Utilización de antagonistas de los receptores de canabinoides centrales para la preparación de medicamentos
Inventor: MARUANI JEANNE
IPC: C07D401/14
Filed: 1998-01-20
Abstract: Utilización de un antagonista de los receptores de los canabinoides centrales, solo o en asociación con un compuesto regulador de los desordenes metabólicos, en especial un agonista del receptor beta3-adrenérgico, para la preparación de medicamentos útiles en el tratamiento de los trastornos del apetito. En especial se incluye el antagonista CB1 de fórmula general (II) representada en la figura 1, y sus composiciones farmacéuticas, donde: R1 representa el hidrógeno, un flúor, in hidroxi, un (C1-C5) alcoxi, un (C1-C5) alquiltio, un hidroxi (C1-C5) alcoxi, un grupo -NR10R11, un ciano, un (C1-C5) alquilsulfonilo o un (C1-C5)alquilsulfonilo; R2 y R3 representan alquilo o junto con el átomo de nitrógeno al que están unidos, constituyen un radical heterocíclico saturado o insaturado de 5 a 10 eslabones, no sustituido o sustituido por un alquilo o por un alcoxi; R4, R5, R6, R7, R8, R9 representan cada uno independientemente hidrógeno, un halógeno o un trifluorometilo, y cuando R1 representa flúor R4, R5, R6, R7, R8 y/o R9 pueden igualmente representar un fluorometilo; a condición que al menos uno de los sustituyentes R4 o R7 sea diferente de hidrógeno. Ejemplo de un compuesto de fórmula general (II): N-piperidino-5-(4-clorofenil)-1-(2,4-diclorofenil)-4-metilpiperazol-3-carboxamida o una de sus sales o solvatos farmacéuticamente aceptables. El antagonista CB1 puede estar asociado a un regulador de los desórdenes metabólicos, en especial un beta3-agonista, como por ejemplo (sin limitar) el representado en la figura 2, donde X es un hidrógeno, halógeno, un trifluorometilo o un alquilo y R es hidrógeno o metilo. Los antagonistas descritos son útiles en el tratamiento de trastornos de conductas alimenticias, como la obesidad (particularmente asociada a la diabetes no-insulino dependiente), bulimia, como en el tratamiento del abuso de dogras o dependencia de las mismas.
Patent UY-25270-A1 (UY)
Title: Barrera para comunicaciones celulares
Inventor: ISRAELI GIL
IPC: H04M3/38
Filed: 1998-11-26
Abstract: Un método y una disposición para controlar el uso de comunicaciones de telefonía celular móvil dentro de un área definida regulada. La disposición transmite señales de interferencia de radiofrecuencia en una banda de frecuencia típicamente usada por estaciones de base celulares para evitar comunicaciones eficientes entre unidades móviles ubicadas dentro de un área dada regulada y estaciones de base celulares. En la realización preferida, la disposición espera hasta se detecta la transmisión de una unidad móvil dentro del área regulada, y luego transmite una señal de bloqueo que evita que se lleve a cabo la rutina de protocolo eficiente. Un método para regulación de comunicaciones celulares en una disposición de comunicaciones dentro de un área dada, comprendiendo dicho método las etapas de: transmitir señalización de estación de base fantasma por un canal de control stancard celular, haciendo dicha señalización que las unidades móviles dentro de un área regulada dada se abstengan de registrar cuan otras estaciones de base locales inhabilitándose de este modo comunicaciones con la red celular desde dentro de dicha área.
Patent UY-27278-A1 (UY)
Title: Forma de dosificación farmacéutica del mesilato de nelfinavir amorfo
Inventor: ZHANG LIN
Filed: 2002-05-02
Abstract: Se proporciona una forma de dosificación farmacéutica oral unitaria sólida de mesilato de nelfinavir amorfo que comprende mesilato de nelfinavir amorfo, y un polímero sintético, no iónico, de bloqueo de óxido de etileno y óxido de propileno, soluble en agua, farmacéuticamente aceptable, teniendo dicho copolímero un punto de fusión de al menos 40sC. Se proporciona un proceso de granulación de fusión caliente para la elaboración de una forma de dosificación.